Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer? - Backes, F.; Richardson, D.; McCann, G.; Salani, R.; Eisenhauer, E.; Fowler, J.; Copeland, L.; Cohn, D.; O'Malley, D. (Gynecologic Oncology, 2012)